Skip to main content

Table 2 Obstetric and perinatal outcomes in women with and without HDP

From: Higher daytime systolic BP, prepregnancy BMI and an elevated sFlt-1/PlGF ratio predict the development of hypertension in normotensive pregnant women

Variable

HDP (n = 14)

Non-HDP (n = 132)

p Value

Obstetric and perinatal outcomes

 Weight gain (kg) *

10.9 ± 5.0

8.8 ± 4.2

0.1

 Gestational age at delivery; (wk) *

38.4 ± 1.8

39.4 ± 1.1

0.06

 Preterm delivery (<  37 wk)†

3 (21.4%)

0

< 0.001

 Instrumental delivery †

5 (35.7%)

30 (22.7%)

0.2

 Cesarean section †

5 (35.7%)

34 (25.8%)

0.3

 Birthweight (g) *

2901 ± 667

3318 ± 472

0.038

 Customized percentile *

28.6 ± 29.8

47.1 ± 29.1

0.026

Neonatal complications †

 Macrosomia

0

16 (12.1%)

0.1

 SGA

6 (42.9%)

16 (12.1%)

0.008

 IUGR

4 (28.6%)

7 (5.3%)

0.012

 Hypoglycemia

3 (21.4%)

4 (3%)

0.002

 Hyperbilirubinemia

1 (7.1%)

6 (4.5%)

0.6

 Congenital malformations

1 (7.1%)

1 (0.8)

0.051

 Admission to the neonatal ICU

1 (7.1%)

5 (3.8%)

0.5

  1. * Data expressed as means ± standard deviation; comparisons between different groups were done by the Student’s t– test for parametric variables and the Mann–Whitney U– test for nonparametric variables
  2. † Data expressed as n (%); comparisons among groups were done using the χ2 test, or Fisher’s exact test for nonparametric contrasting
  3. SGA small for gestational age, IUGR intrauterine growth restriction